Results of NETest liquid biopsy in high-grade gastroenteropancreatic neuroendocrine neoplasms

被引:0
|
作者
Sorbye, H. [1 ]
Langer, S. W. [2 ]
Hjortland, G. O. [3 ]
Vestermark, L. W. [4 ]
Sundlov, A. [5 ]
Assmus, J. [6 ]
Perren, A. [7 ]
Kidd, M. [8 ]
机构
[1] Haukeland Hosp, Dept Oncol, Bergen, Norway
[2] Copenhagen Univ Hosp, Dept Oncol, Rigshosp, Copenhagen, Denmark
[3] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[4] Univ Southern Denmark, Dept Clin Med, Fac Hlth Sci, Odense, Denmark
[5] Skane Univ Hosp, Dept Oncol, Lund, Sweden
[6] Haukeland Hosp, Ctr Clin Res, Bergen, Norway
[7] Univ Bern, GInstitute Pathol, Bern, Switzerland
[8] Wren Labs, Branford, CT USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
F21
引用
收藏
页码:151 / 151
页数:1
相关论文
共 50 条
  • [31] Comprehensive genomic sequencing of high-grade neuroendocrine neoplasms
    Sun, Thomas Yang
    Van Hummelen, Paul
    Martin, Brock
    Xia, Charlie
    Lee, Hojoon
    Zhao, Lan
    Hornbacker, Kathleen
    Ji, Hanlee
    Kunz, Pamela L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [32] The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
    Malczewska, Anna
    Kos-Kudla, Beata
    Kidd, Mark
    Drozdov, Ignat
    Bodei, Lisa
    Matar, Somer
    Oberg, Kjell
    Modlin, Irvin M.
    [J]. ADVANCES IN MEDICAL SCIENCES, 2020, 65 (01): : 18 - 29
  • [33] Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
    Morken, Siren
    Langer, Seppo W.
    Sundlov, Anna
    Vestermark, Lene Weber
    Ladekarl, Morten
    Hjortland, Geir Olav
    Svensson, Johanna B.
    Tabaksblat, Elizaveta Mitkina
    Haslerud, Torjan Magne
    Assmus, Jorg
    Detlefsen, Sonke
    Couvelard, Anne
    Perren, Aurel
    Sorbye, Halfdan
    [J]. BRITISH JOURNAL OF CANCER, 2023, 129 (12) : 1930 - 1939
  • [34] Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
    Siren Morken
    Seppo W. Langer
    Anna Sundlöv
    Lene Weber Vestermark
    Morten Ladekarl
    Geir Olav Hjortland
    Johanna B. Svensson
    Elizaveta Mitkina Tabaksblat
    Torjan Magne Haslerud
    Jörg Assmus
    Sönke Detlefsen
    Anne Couvelard
    Aurel Perren
    Halfdan Sorbye
    [J]. British Journal of Cancer, 2023, 129 : 1930 - 1939
  • [35] Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus
    Genc, Cansu G.
    Klumpen, Heinz-Josef
    Denecke, Timm
    Wiedenmann, Bertram
    Pavel, Marianne
    [J]. ACTA ONCOLOGICA, 2018, 57 (05) : 686 - 688
  • [36] Efficacy of ipilimumab and nivolumab in patients with high-grade neuroendocrine neoplasms
    Al-Toubah, T.
    Halfdanarson, T.
    Gile, J.
    Morse, B.
    Sommerer, K.
    Strosberg, J.
    [J]. ESMO OPEN, 2022, 7 (01)
  • [37] Efficacy of Ipilimumab and Nivolumab in Patients With High-grade Neuroendocrine Neoplasms
    Al-Toubah, Taymeyah
    Halfdanarson, Thorvardur
    Gile, Jennifer
    Morse, Brian
    Sommerer, Katelynn
    Strosberg, Jonathan
    [J]. PANCREAS, 2022, 51 (03) : E40 - E40
  • [38] Impact of Postoperative Chemotherapy on the Survival of Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinoma
    Schmitz, Robin
    Mao, Rui
    Moris, Dimitrios
    Strickler, John H.
    Blazer, Dan, III
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (01) : 114 - 120
  • [39] Antitumor Effect of Everolimus in Preclinical Models of High-Grade Gastroenteropancreatic Neuroendocrine Carcinomas
    Bollard, Julien
    Couderc, Christophe
    Blanc, Martine
    Poncet, Gilles
    Lepinasse, Florian
    Hervieu, Valerie
    Gouysse, Geraldine
    Ferraro-Peyret, Carole
    Benslama, Noura
    Walter, Thomas
    Scoazec, Jean-Yves
    Roche, Colette
    [J]. NEUROENDOCRINOLOGY, 2013, 97 (04) : 331 - 340
  • [40] Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms
    Leoncini, Emanuele
    Boffetta, Paolo
    Shafir, Michail
    Aleksovska, Katina
    Boccia, Stefania
    Rindi, Guido
    [J]. ENDOCRINE, 2017, 58 (02) : 368 - 379